Characterization of Potassium Channel Modulators with QPatch™ Automated Patch-Clamp Technology: System Characteristics and Performance-Reference-Cited by-同舟云学术

Characterization of Potassium Channel Modulators with QPatch™ Automated Patch-Clamp Technology: System Characteristics and Performance

Published:2003-10 Issue:5 Volume:1 Page:685-693
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Kutchinsky Jonatan¹,Friis Søren,Asmild Margit,Taboryski Rafael,Pedersen Simon,Vestergaard Ras K.,Jacobsen Rasmus B.,Krzywkowski Karen,Schrøder Rikke L.,Ljungstrøm Trine,Hélix Nathalie,Sørensen Claus B.,Bech Morten,Willumsen Niels J.²

Affiliation:

1. Sophion Bioscience A/S, Ballerup, Denmark

2. Sophion Bioscience A/S, Baltorpvej 154, DK-2750 Ballerup, Denmark. njw@sophion.dk

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/154065803770381048

Reference16 articles.

1. Single-channel currents recorded from membrane of denervated frog muscle fibres

2. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease;Journal of Medicinal Chemistry;2024-06-07

2. Development of automated patch clamp assays to overcome the burden of variants of uncertain significance in inheritable arrhythmia syndromes;Frontiers in Physiology;2023-11-27

3. Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability;Journal of Medicinal Chemistry;2023-03-24

4. Synthesis and Biological Evaluation of 3′,5′‐d₂‐Cannabidiol;ChemistrySelect;2023-01-02

5. Discovery of Indole-Containing Benzamide Derivatives as HDAC1 Inhibitors with In Vitro and In Vivo Antitumor Activities;Pharmaceutical Fronts;2022-06